collaboration & cooperation among regulatory agencies ... · actd the part of marketing...
TRANSCRIPT
ThaiFDA
Yuppadee-14th ICDRA 1
Plenary 4- Collaboration & Cooperation among Regulatory Agencies“Recent Developments in Cooperation of
Regulatory Authorities among ASEAN countries”
byYuppadee JAVROONGRIT, Ph.D.
Assistant Director, Drug Control Division, FDA, ThailandThe 14th ICDRA
Raffles City Convention Centre, Singapore29 November 2010
ThaiFDA
Yuppadee-14th ICDRA 2
• the ASEAN & cooperation• PPWG• AWGPD• Recommendation
Topics
ThaiFDA
Yuppadee-14th ICDRA 3
• the ASEAN & cooperation• PPWG• AWGPD• Recommendation
Topics
ThaiFDA
Yuppadee-14th ICDRA 4
established = 8 Aug. 1967size ~ 4.5 mil.Km2
total population ~ 580 million
- Brunei Darussalam- Cambodia- Indonesia- Lao PDR- Malaysia- Myanmar- Phillippines- Singapore- Thailand- Vietnam
ASEAN = Association of Southeast Asian Nations
ThaiFDA
Yuppadee-14th ICDRA 5
• Objective :(1) accelerate the economic growth, social progress, and
cultural development(2) promote regional peace and stability
• 1995 – ASEAN Leaders reaffirmed that :“Cooperative peace and shared prosperity shall be the Fundamental goals of ASEAN”
The ASEAN (1)
ThaiFDA
Yuppadee-14th ICDRA 6Yuppadee – 8Jun2010, Tallinn, Estonia
• Fundamental principle :(i) Mutual respect for the independence, sovereignty, equality
territorial integrity, and national identity of all nations(ii) The right to lead its national existence free from external
interference, subversion, or coercion(iii) Non-interference in the internal affairs of one another(iv) Settlement of differences or disputes by peaceful manner(v) Renunciation of the treat or use of force, (vi) Effective cooperation among themselves
The ASEAN (2)
ThaiFDA
Yuppadee-14th ICDRA 7
The ASEAN- Major Collaboration & Cooperation
ASEAN Summit
- Economic Cooperation-AEM - Political & Security Cooperation- Socio-cultural Cooperation
The Leader (Presidents, Prime Minister)
Minister of Economic/Trade MinistryMinister of Foreign Affairs Ministry
ThaiFDA
Yuppadee-14th ICDRA 8
The ASEAN- Major Collaboration & Cooperation
ASEAN Summit
- Economic Cooperation-AEM - Political & Security Cooperation- Socio-cultural Cooperation
The Leader (Presidents, Prime Minister)
Minister of Economic/Trade MinistryMinister of Foreign Affairs Ministry
AFTAAEC
ThaiFDA
Yuppadee-14th ICDRA 9
ASEAN Leader Summit
ASEAN Economic Community (AEC)“by the year 2015….. ASEAN will be
Single Market and Single Production BaseFree flow of GoodsFree flow of ServicesFree flow of InvestmentFree flow of CapitalsFree flow of Skilled Labour
The Latest Goal of ASEAN
ThaiFDA
Yuppadee-14th ICDRA 10
the AECaim create stable, prosperous, and highly competitive
ASEAN Economic region
shall establish ASEAN as Single Market and Production baseinstitute new mechanisms and measures to strengthen
the implementation of its existing economic initiatives –AFTA, AFAS, and AIA
accelerate regional integration in the Priority sectorimprove the Dispute Settlement Mechanism
ThaiFDA
Yuppadee-14th ICDRA 11
The ASEAN- CooperationASEAN Summit
Economic Cooperation-AEM - Political & Security Cooperation- Socio-cultural Cooperation
WG1 - Mutual Recognition Arrangements (MRAs) & StandardsWG2 - Accreditation and Conformity Assessment Sub-WG - Scientific/Industrial Metrology
SEOMACCSQ
ACC - ASEAN Committee on CosmeticPPWG - Pharmaceuticals PWGEE PWG- Electrical and Electronic PWGPf PWG - Prepared Foodstuff PWGTMHS PWG - Traditional Medicine & Health Supplement PWGMedical Devices&Equipment PWGA PWG - Automotives PWGRB PWG - Rubber-based PWG…….
AWGPD – ASEAN Working Gr. on Pharmaceuticals Dev.ASEAN Sectoral Working on Traditional MedicineInitiatives on Traditional Medicine
AFTAAEC
AHMMASCC CouncilASODSOMHD
ThaiFDA
Yuppadee-14th ICDRA 12
• the ASEAN & cooperation• PPWG• AWGPD• Recommendation
Topics
ThaiFDA
Yuppadee-14th ICDRA 13
PPWG ACCSQ/PPWGASEAN Consultative Committee
for Standards and Quality / Pharmaceutical Product Working Group
Objective:to develop harmonization scheme of Pharmaceuticals regulations of the ASEAN member countries, to complement and facilitate the objective of AFTA, particularly, the elimination of Technical Barriers to Trade posed by the regulations, without compromising on drug quality, efficacy, and safety”
& facilitate the AEC !!!!
ThaiFDA
Yuppadee-14th ICDRA 14
Principle to promote “Registration”, “Trade”, & “Co-operation”to eliminate “TBT”
Scope to harmonize “ASEAN Pharmaceutical Registration”
Output ASEAN Harmonized Product (ACTR, ACTD, guidelines)
Mutual Recognition Agreement (MRA)
PPWG
ThaiFDA
Yuppadee-14th ICDRA 15
Working Scheme of the PPWGComparative study
on Registration Requirement & Regulation
Agreement(ASEAN Harmonized Product, MRAs)
Identification the “Key Area on Requirements”for Harmonization
the Works -“Lead Countries”/Members
the Meetings
Implementation &Capacity Building/Strengthening
Endorsement (ACCSQ / SEOM / AEM /…)
- Tech. discussion gr.- Dialogue w/ Association - IWG- MRA Task forces - HOD- PPWG
Current Activities
• Implementing ASEAN Har.products- for new application - for existing Drug license (by 2012)
• Establishing GMP-MRA JSC• MRA-BA/BE Study Report• Updating Tech.gls.• Variation guideline• New ares of integration: Biological , Biotech.,
Biosimilar product• Facilitating the AEC • Coop. with international forum: WHO, ICH, etc.• Training activities
Agreement• ACTR, ACTD, Technical guidelines• Full implementation timeline• ASEAN Sectoral MRA on GMP Inspection• Vaccine Chapter
ThaiFDA
Yuppadee-14th ICDRA 16
ACTRA set of Written Materials intended to guideapplicants to prepare application dossiers
in a way that is consistent with the expectations of
all ASEAN Drug Regulatory Authorities
ACTDThe part of
marketing authorization application dossierthat is common to all ASEAN member
countries
Technical guidelines• Quality
(1) Analytical Validation guideline(2) BA/BE Studies guideline(3) Process Validation guideline(4) Stability Study guideline
• Safety :- adopted 15 ICH-Safety gls.
• Efficacy- adopted 11 ICH-Efficacy gls.- accepted as Ref.gls. 4 ICH-Efficacy gls.
ThaiFDA
Yuppadee-14th ICDRA 17
Cooperation “PPWG & WHO” – Vaccine Chapter• initiated by Dr.Liliana CHOCARRO (WHO)
- aiming to expand benefit of DCVRN for the whole region• started in the 10th PPWG Meeting (Aug.2005)• focusing in Capacity Building on Vaccine Regulation• Survey on Country’s Need for capacity building on Vaccine CT evaluation/regulation• Main cooperation;
- sharing info. (guidelines, template for regulatory procedures, DCVRN, ….)- invitation to ASEAN members to attend the DCVRN Meeting (s)- regulatory pathway workshop- training courses by WHO/GTN on “Clinical Trial Authorization”, “Clinical Data Evaluation for
Vaccine Registration”, and “GCP Inspection”• The 17th PPWG Meeting (Jul.2010);
- noted the proposal to WHO for continuous support in capacity building efforts related to the vaccine regulation.
- recorded appreciation to WHO and Dr Liliana CHOCARRO for all supports to the ASEAN Member States with regards to the Vaccine Regulatory Framework
ThaiFDA
Yuppadee-14th ICDRA 18
Cooperation “PPWG & ICH” – the GCG
• started from ICH 6(Yr 2003)• invited by ICH to the ICH-GCG Meeting. The PPWG decided to attend
as an Observer, and assigned Co-Chair to be the Rep. since May 2004.• Main cooperation;
- sharing of info. (output from Meetings, on relevant topics, ASEAN profile, ICH website)
- invitation to comment on Step 2 and 4 of ICH-Technical guidelines- utilization and adoption of ICH Technical guidelines- training supports (Speakers)
• the recent Training supports (Yr.2009-11);- on Training project: MedDRA(23-25 Nov.09), Q8-9-10(26-28 Jul.10),
and Q5C(on-going)
ThaiFDA
Yuppadee-14th ICDRA 19
• the ASEAN & cooperation• PPWG• AWGPD• Recommendation
Topics
ThaiFDA
Yuppadee-14th ICDRA 20
The ASEAN- CooperationASEAN Summit
Economic Cooperation-AEM - Political & Security Cooperation- Socio-cultural Cooperation
AFTAAEC
AHMM, ASCC Council, ASODSOMHDAWGPD
• ASEAN Strategic Framework on Health Development• ASEAN Coop. in Traditional Medicine
• Coop. with WHO/Dialogue partners
• Programme of Good Manufacturing Practices [Id]• Standardization, Quality Control and Validation of Herbal Medicine [Id & Th]• Programme to Promote Rational Drug Use [Bn & Sg]• Collaborating Center for the Production of ASEAN Reference Substances [Th]• Programme for Drug Evaluation [Ph]• Building up and Strengthening ASEAN’s Capacity in GCP and CTs [Th]• ASEAN Collaboration in Combating Counterfeit Drug [Id]• Building up and Strengthening of Pharmacovigilance System in ASEAN [Sg]
ThaiFDA
Yuppadee-14th ICDRA 21
The ASEAN- CooperationASEAN Summit
Economic Cooperation-AEM - Political & Security Cooperation- Socio-cultural Cooperation
AFTAAEC
AHMM, ASCC Council, ASODSOMHDAWGPD
- ASEAN Strategic Framework on Health Development-ASEAN Coop. in Traditional Medicine
-Coop. with WHO/Dialogue partners
• Programme of Good Manufacturing Practices [Id]• Standardization, Quality Control and Validation of Herbal Medicine [Id & Th]• Programme to Promote Rational Drug Use [Bn & Sg]• Collaborating Center for the Production of ASEAN Reference Substances [Th]• Programme for Drug Evaluation [Ph]• Building up and Strengthening ASEAN’s Capacity in GCP and CTs [Th]• ASEAN Collaboration in Combating Counterfeit Drug [Id]• Building up and Strengthening of Pharmacovigilance System in ASEAN [Sg]
ThaiFDA
Yuppadee-14th ICDRA 22
The ASEAN- CooperationASEAN Summit
Economic Cooperation-AEM - Political & Security Cooperation- Socio-cultural Cooperation
AFTAAEC
AHMM, ASCC Council, ASODSOMHDAWGPD
- ASEAN Strategic Framework on Health Development-ASEAN Coop. in Traditional Medicine
-Coop. with WHO/Dialogue partners
• Programme of Good Manufacturing Practices [Id]• Standardization, Quality Control and Validation of Herbal Medicine [Id & Th]• Programme to Promote Rational Drug Use [Bn & Sg]• Collaborating Center for the Production of ASEAN Reference Substances [Th]• Programme for Drug Evaluation [Ph]• Building up and Strengthening ASEAN’s Capacity in GCP and CTs [Th]• ASEAN Collaboration in Combating Counterfeit Drug [Id]• Building up and Strengthening of Pharmacovigilance System in ASEAN [Sg]
Activities;• Training (with supports from APEC-LSIF & ICH-GCG)
Next steps.:- it could be…• follow-up in Implementation of the Training outcome• Regulatory pathway for Clinical Trials/Development on;
- Neglected Diseases- Multi-regional Clinical Trial- Pediatric Clinical Trial
• networking for “regional assessment for Clinical Trial Application of Pandemic / Multi-national Clinical Trial”, with WHO coordinating/support• …..(need further discussion/works)
ThaiFDA
Yuppadee-14th ICDRA 23
• the ASEAN & cooperation• PPWG• AWGPD• Recommendation
Topics
ThaiFDA
Yuppadee-14th ICDRA 24
• type of strong coop.- the Mutual Agreements- ACTR &ACTD- Technical guideline- MRA
• achievement ;- friendship & trust & supportive- sharing of info. & work- mutual benefit
• essential ;- contribution & commitment- identify & prioritize the Topics/Areas of coop.- keep DRA’s role, while facilitating Leader Mandate/Globalization
Experienced from ASEAN Coop.
ThaiFDA
Yuppadee-14th ICDRA 25
Together !!!Thank You ...